Skip to main content
Clinical Trials/NCT03326726
NCT03326726CompletedPhase 2

Evaluation of the Area Covered by Medline 2% Chlorhexidine Gluconate Cloth Preoperative Skin Preparation

Medline Industries0 sites30 target enrollmentStarted: November 16, 2016Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
30
Primary Endpoint
Medline 2% CHG Cloth Dosage of Coverage Area

Study Overview

Brief Summary

Medline 2% CHG cloth (Active) - A single cloth from the pack was used per treatment area. The investigational test article was applied topically by vigorously scrubbing the skin in a back and forth motion for three minutes (and halfway through the 3-minute application time, the cloth was turned over) over the treatment area (7" x 10" of the subject's back), and the skin was allowed to air dry.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Healthy males of at least 18 years of age having skin within 6 inches of the test regions that were free of tattoos, dermatoses, abrasions, cuts, lesions or other skin disorders, with no history of sensitivity to CHG and were able to lie prone for up to 30 minutes.

Exclusion Criteria

  • Not provided

Arms & Interventions

Chlorhexidine Gluconate

Experimental

2% CHG

Intervention: 2% CHG (Drug)

Outcomes

Primary Outcomes

Medline 2% CHG Cloth Dosage of Coverage Area

Time Frame: 3 minutes

To measure the dosage of the coverage area of a single investigational test article, Medline 2% CHG cloth calculated in grams per square centimeter

Secondary Outcomes

  • Post-application Drying Time(Approximately 1 minute)

Investigators

Sponsor
Medline Industries
Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials